Skip to main content

Table 6 Associations between microRNA-144-3p expression and clinicopathological features in lung squamous cell carcinoma, based on quantitative real-time PCR data

From: Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data

Clinicopathological feature   n mean ± SD p value
Tissue Adjacent non-cancerous tissue 23 5.405 ± 2.684 0.0004*
LUSC 23 2.964 ± 1.264
Age (years) <  60 15 2.872 ± 1.39748 0.611
≥ 60 8 3.1375 ± 1.03086
Gender Female 5 2.976 ± 0.6827 0.974
Male 18 2.9611 ± 1.39922
Tumor size (cm) ≤ 3 7 3.02 ± 1.79763 0.915
>  3 16 2.94 ± 1.02398
Smoke No 12 2.6733 ± 1.1468 0.263
Yes 11 3.2818 ± 1.36222
Lymph node metastasis No 11 3.0436 ± 1.48816 0.784
Yes 12 2.8917 ± 1.08163
Vascular invasion No 20 2.919 ± 0.99752 0.667
Yes 3 3.2667 ± 2.82194
TNM I–II 10 2.978 ± 0.89643 0.963
III–IV 13 2.9538 ± 1.52513
  1. SD Standard deviation, LUSC Lung squamous cell carcinoma
  2. *p < 0.05 was considered statistically significant